A PHASE II RANDOMIZED STUDY OF NovoTTF THERAPY VERSUS SUPPORTIVE CARE IN NON-SMALL CELL LUNG CANCER PATIENTS WITH 1-5 BRAIN METASTASES FOLLOWING OPTIMAL STANDARD LOCAL TREATMENT

被引：0
|
作者：
Weinberg, Uri [1 ]
Kirson, Eilon [2 ]
Farber, Ori [2 ]
Palti, Yoram [1 ]
机构：
[1] Novocure GmbH, Luzern, Switzerland
[2] Novocure Ltd, Haifa, Israel
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
10.1093/neuonc/nou265.35
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NT-37
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A Phase II Trial of Pembrolizumab for Untreated Brain Metastases from Non-Small Cell Lung Cancer
    Goldberg, Sarah B.
    Gettinger, Scott N.
    Mahajan, Amit
    Herbst, Roy
    Chiang, Anne
    Tsiouris, Apostolos J.
    Vortmeyer, Alexander
    Jilaveanu, Lucia
    Speaker, Stephanie
    Madura, Matthew
    Rowen, Elin
    Gerrish, Heather
    Yao, Xiaopan
    Chiang, Veronica
    Kluger, Harriet
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S234 - S235
  • [42] Treatment and outcome of patients with brain metastases from non-small cell lung cancer (NSCLC)
    Ali, A.
    Goffin, J. R.
    Arnold, A.
    Ellis, P. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] Motexafin gadolinium injection for the treatment of brain metastases in patients with non-small cell lung cancer
    Thomas, Sayana R.
    Khuntia, Deepak
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2007, 2 (01): : 79 - 87
  • [44] Methods and results of locoregional treatment of brain metastases in patients with non-small cell lung cancer
    Patla, Anna
    Walasek, Tomasz
    Jakubowicz, Jerzy
    Blecharz, Pawel
    Mitus, Jerzy Wladyslaw
    Mucha-Malecka, Anna
    Reinfuss, Marian
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2016, 20 (05): : 358 - 364
  • [45] Postoperative versus definitive Stereotaxy for synchronous Brain Metastases in Patients with non-small cell Lung Cancer
    Nagaraja, S.
    Hultenschmidt, B.
    Nadji, S.
    Frank, N.
    Lindel, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S65 - S66
  • [46] Chemotherapy Plus Best Supportive Care versus Best Supportive Care in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
    Zhong, Chenxi
    Liu, Hongcheng
    Jiang, Liyan
    Zhang, Wei
    Yao, Feng
    PLOS ONE, 2013, 8 (03):
  • [47] Weekly gemcitabine as a radiosensitiser for the treatment of brain metastases in patients with non-small cell lung cancer: phase I trial
    Huang Yu-juan
    Wu Yi-long
    Xie Song-xi
    Yang Jing-ji
    Huang Yi-sheng
    Liao Ri-qiang
    CHINESE MEDICAL JOURNAL, 2007, 120 (06) : 458 - 462
  • [48] Outcomes Following Gamma Knife Radiosurgery in Patients with Non-Small Cell Lung Cancer with Brain Metastases
    Coen, O.
    El Badri, S.
    Hatfield, P.
    Franks, K.
    Jain, P.
    Snee, M.
    Clarke, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2091 - S2091
  • [49] Phase II Study of the Efficacy and Safety of High-dose Pemetrexed in Combination with Cisplatin Versus Temozolomide for the Treatment of Non-small Cell Lung Cancer with Brain Metastases
    He, Qiaowei
    Bi, Xizhuang
    Ren, Chao
    Wang, Yong
    Zou, Peng
    Zhang, Hongtao
    Chi, Nan
    Xiu, Chunming
    Wang, Yunbo
    Tao, Rongjie
    ANTICANCER RESEARCH, 2017, 37 (08) : 4711 - 4716
  • [50] Patupilone for the treatment of recurrent/progressive brain metastases in patients (pts) with non-small cell lung cancer (NSCLC): An open-label phase II study
    Abrey, L. E.
    Wen, P.
    Govindan, R.
    Reimers, H.
    Rigas, J. R.
    Robins, H. I.
    Allen-Freda, E.
    Gao, B.
    Ko, J.
    Johri, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345